From the Departments of Vascular Medicine (D.M.K., J.J.P.K.), Pediatrics (D.M.K., A.W.), and Clinical Epidemiology, Biostatistics, and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands.
Circ Res. 2014 Jan 17;114(2):307-10. doi: 10.1161/CIRCRESAHA.114.301430. Epub 2013 Nov 5.
Familial hypercholesterolemia (FH) predisposes patients to premature cardiovascular disease, with the process of atherosclerosis initiated in early childhood.
As part of an ongoing trial to assess the efficacy and safety of rosuvastatin in children with FH aged 6 to 17 years, we report the differences in carotid intima-media thickness (cIMT) at baseline between children with FH and their unaffected siblings.
B-mode ultrasound measurements of the carotid artery were made in 196 children with FH and 64 of their siblings. Mean (±SE) cIMT in children with FH was significantly greater than that of unaffected siblings (0.398±0.052 versus 0.377±0.045 mm; P<0.001). A significantly greater cIMT value was observed before the age of 8 years. Multivariable analyses showed that age, male sex, and presence of FH were independent predictors of cIMT.
The difference in mean cIMT between children with FH and their unaffected siblings may be significant as early as age 8 years. This study confirms the need for early cholesterol lowering in this high-risk population. These patients participating in a carefully monitored study will help assess the long-term efficacy on cIMT and safety of statin therapy in young children.
家族性高胆固醇血症(FH)使患者易患早发性心血管疾病,动脉粥样硬化过程始于儿童早期。
作为评估瑞舒伐他汀在 6 至 17 岁 FH 儿童中的疗效和安全性的正在进行的试验的一部分,我们报告了 FH 儿童与未受影响的兄弟姐妹之间基线时颈动脉内膜中层厚度(cIMT)的差异。
对 196 名 FH 儿童和 64 名其未受影响的兄弟姐妹进行了颈动脉 B 型超声测量。FH 儿童的平均(±SE)cIMT 明显大于未受影响的兄弟姐妹(0.398±0.052 与 0.377±0.045 mm;P<0.001)。在 8 岁之前观察到更大的 cIMT 值。多变量分析显示,年龄、男性和 FH 的存在是 cIMT 的独立预测因素。
FH 儿童与未受影响的兄弟姐妹之间平均 cIMT 的差异早在 8 岁时就可能很明显。本研究证实了在这一高危人群中早期降低胆固醇的必要性。这些参与精心监测研究的患者将有助于评估他汀类药物治疗在幼儿中的长期 cIMT 疗效和安全性。